13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Extracellular lysophosphatidic acid (LPA) species transmit signals via six different G protein-coupled receptors (LPAR1–6) and are indispensible for brain development and function of the nervous system. However, under neuroinflammatory conditions or brain damage, LPA levels increase, thereby inducing signaling cascades that counteract brain function. We describe a critical role for 1-oleyl-2-hydroxy-sn-glycero-3-phosphate (termed “LPA” throughout our study) in mediating a motile and pro-inflammatory microglial phenotype via LPAR5 that couples to protein kinase D (PKD)-mediated pathways.

          Methods

          Using the xCELLigence system and time-lapse microscopy, we investigated the migrational response of microglial cells. Different M1 and M2 markers were analyzed by confocal microscopy, flow cytometry, and immunoblotting. Using qPCR and ELISA, we studied the expression of migratory genes and quantitated the secretion of pro-inflammatory cytokines and chemokines, respectively. Different transcription factors that promote the regulation of pro-inflammatory genes were analyzed by western blot. Reactive oxygen species (ROS) and nitric oxide (NO) production, phagocytosis, and microglial cytotoxicity were determined using commercially available assay kits.

          Results

          LPA induces MAPK family and AKT activation and pro-inflammatory transcription factors’ phosphorylation (NF-κB, c-Jun, STAT1, and STAT3) that were inhibited by both LPAR5 and PKD family antagonists. LPA increases migratory capacity, induces secretion of pro-inflammatory cytokines and chemokines and expression of M1 markers, enhances production of ROS and NO by microglia, and augments cytotoxicity of microglial cell-conditioned medium towards neurons. The PKD family inhibitor blunted all of these effects. We propose that interference with this signaling axis could aid in the development of new therapeutic approaches to control neuroinflammation under conditions of overshooting LPA production.

          Conclusions

          In the present study, we show that inflammatory LPA levels increased the migratory response of microglia and promoted a pro-inflammatory phenotype via the LPAR5/PKD axis. Interference with this signaling axis reduced microglial migration, blunted microglial cytotoxicity, and abrogated the expression and secretion of pro-inflammatory mediators.

          Electronic supplementary material

          The online version of this article (10.1186/s12974-017-1024-1) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references80

          • Record: found
          • Abstract: found
          • Article: not found

          Glioblastoma: Defining Tumor Niches.

          Glioblastomas (GBM) are one of the most recalcitrant brain tumors because of their aggressive invasive growth and resistance to therapy. They are highly heterogeneous malignancies at both the molecular and histological levels. Specific histological hallmarks including pseudopalisading necrosis and microvascular proliferation distinguish GBM from lower-grade gliomas, and make GBM one of the most hypoxic as well as angiogenic tumors. These microanatomical compartments present specific niches within the tumor microenvironment that regulate metabolic needs, immune surveillance, survival, invasion as well as cancer stem cell maintenance. Here we review features and functions of the distinct GBM niches, detail the different cell constituents and the functional status of the vasculature, and discuss prospects of therapeutically targeting GBM niche constituents.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.

            Lysophosphatidic acid (LPA) is a bioactive lipid with activity in the nervous system mediated by G-protein-coupled receptors. Here, we examined the role of LPA signaling in the development of neuropathic pain by pharmacological and genetic approaches, including the use of mice lacking the LPA(1) receptor. Wild-type animals with nerve injury develop behavioral allodynia and hyperalgesia paralleled by demyelination in the dorsal root and increased expression of both the protein kinase C gamma-isoform within the spinal cord dorsal horn and the alpha(2)delta(1) calcium channel subunit in dorsal root ganglia. Intrathecal injection of LPA induced behavioral, morphological and biochemical changes similar to those observed after nerve ligation. In contrast, mice lacking a single LPA receptor (LPA(1), also known as EDG2) that activates the Rho-Rho kinase pathway do not develop signs of neuropathic pain after peripheral nerve injury. Inhibitors of Rho and Rho kinase also prevented these signs of neuropathic pain. These results imply that receptor-mediated LPA signaling is crucial in the initiation of neuropathic pain.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Factors regulating microglia activation

              Microglia are resident macrophages of the central nervous system (CNS) that display high functional similarities to other tissue macrophages. However, it is especially important to create and maintain an intact tissue homeostasis to support the neuronal cells, which are very sensitive even to minor changes in their environment. The transition from the “resting” but surveying microglial phenotype to an activated stage is tightly regulated by several intrinsic (e.g., Runx-1, Irf8, and Pu.1) and extrinsic factors (e.g., CD200, CX3CR1, and TREM2). Under physiological conditions, minor changes of those factors are sufficient to cause fatal dysregulation of microglial cell homeostasis and result in severe CNS pathologies. In this review, we discuss recent achievements that gave new insights into mechanisms that ensure microglia quiescence.
                Bookmark

                Author and article information

                Contributors
                ioanna.plastira@medunigraz.at
                eva.bernhart@medunigraz.at
                madeleine.goeritzer@medunigraz.at
                trevor.devaney@medunigraz.at
                helga.reicher@medunigraz.at
                astrid.hammer@medunigraz.at
                birgit.lohberger@medunigraz.at
                andrea.wintersperger@medunigraz.at
                benjamin.zucol@edu.uni-graz.at
                wolfgang.graier@medunigraz.at
                dagmar.kratky@medunigraz.at
                ernst.malle@medunigraz.at
                +43-316-380-4188 , wolfgang.sattler@medunigraz.at
                Journal
                J Neuroinflammation
                J Neuroinflammation
                Journal of Neuroinflammation
                BioMed Central (London )
                1742-2094
                19 December 2017
                19 December 2017
                2017
                : 14
                : 253
                Affiliations
                [1 ]ISNI 0000 0000 8988 2476, GRID grid.11598.34, Institute of Molecular Biology and Biochemistry, , Medical University of Graz, ; Neue Stiftingtalstrasse 6/6, 8010 Graz, Austria
                [2 ]GRID grid.452216.6, BioTechMed-Graz, ; Graz, Austria
                [3 ]ISNI 0000 0000 8988 2476, GRID grid.11598.34, Institute of Biophysics, , Medical University of Graz, ; Graz, Austria
                [4 ]ISNI 0000 0000 8988 2476, GRID grid.11598.34, Institute of Cell Biology, Histology and Embryology, , Medical University of Graz, ; Graz, Austria
                [5 ]ISNI 0000 0000 8988 2476, GRID grid.11598.34, Department of Orthopedic Surgery, , Medical University of Graz, ; Graz, Austria
                Article
                1024
                10.1186/s12974-017-1024-1
                5735906
                29258556
                28df2ed6-048d-44f3-bc3e-6f1fdacd0ae7
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 19 September 2017
                : 6 December 2017
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Neurosciences
                bioactive lipids,lpar5,pkds,signal transduction,migration,pro-inflammatory mediators
                Neurosciences
                bioactive lipids, lpar5, pkds, signal transduction, migration, pro-inflammatory mediators

                Comments

                Comment on this article